期刊文献+

嗅神经母细胞瘤外科治疗分析 被引量:4

Surgical treatment and out come of olfactory neuroblastoma
下载PDF
导出
摘要 目的总结嗅神经母细胞瘤外科治疗经验。方法回顾性分析2001年1月~2012年3月在我院接受手术治疗的49例嗅神经母细胞瘤病例资料,对预后因素及手术疗效进行研究。结果随访时间6~130个月,中位随访时间44个月。单纯鼻内镜手术31例,鼻内镜辅助手术4例,开放性手术14例。3、5年总体生存率分别为77.8%和69.2%,3、5年无病生存率分别为66.9%和63.2%。颅内受侵和切缘阳性分别为预后不良和复发的独立危险因素。结论鼻内镜手术适用于绝大多数嗅神经母细胞瘤病例,其远期疗效仍需进一步观察。 OBJECTIVE To summarize the experience of surgical treatment of olfactory neuroblastoma. METHODS A retrospective review of 49 patients with olfactory neuroblastoma operated in our hospital between January 2001 and March 2012 was performed. Prognostic factors and efficacy of surgical treatment were analyzed. RESULTS The median follow-up time was 44 months, with a range from 6 to 130 months. Thirty-one patients underwent endoscopic surgery alone, while 4 patients were treated with endoscope-assisted surgery and 14 patients by open surgery. The 3-year and 5-year overall survival(OS) rates were 77.8% and 69.2% respectively. The 3-year and 5-year disease free survival(DFS) rates were 66.9% and 63.2% respectively. Intracranial extension of the disease and positive surgical margins were independent predictors of worse OS and DFS on multivariate analysis. CONCLUSION This retrospective study demonstrates that the endoscopic surgery be suitable to most patients with olfactory neuroblastoma, but long-term follow-up is still necessary.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2014年第9期449-453,共5页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 高等学校博士学科点专项科研基金(20121107110021) 北京市医管局临床医学发展专项(扬帆计划)(XMLX201311)联合资助
关键词 头颈部肿瘤 外科手术 治疗结果 嗅神经母细胞瘤 生存分析 Head and Neck Neoplasms Surgical Procedures Operative Treatment Outcome esthesioneuroblastoma survival analysis
  • 相关文献

参考文献19

  • 1Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res, 1997, 17: 2683-2706.
  • 2Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. 690.
  • 3Jethanamest D, Morris Lancet Oncol, 2001, 2: 683- LG, Sikora AG, et al Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surgery, 2007, 133: 276-280.
  • 4Song CM, Won TB, Lee CH, et al. Treatment modalities and outcomes of olfactory neuroblastoma. Laryngoscope, 2012, 122: 2389-2395.
  • 5陈艳峰,杨安奎,张诠,欧阳电,陈文宽,陈福进.53例嗅神经母细胞瘤的临床分析[J].癌症,2009,28(3):308-311. 被引量:9
  • 6Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer, 1976, 37: 1571-1576.
  • 7Foote RL, Morita A, Ebersold M J, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys, 1993, 27: 835-842.
  • 8Dulguerov P, Caleaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope, 1992, 102: 843-849.
  • 9Patel SG, Singh B, Stambuk HE, et al. Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base, 2012, 73: 208-220.
  • 10Kraus DH, Shah JP, Arbit E, et al. Complications of craniofacial resection for tumors involving the anterior skull base. Head Neck, 1994, 16: 307-312.

二级参考文献11

  • 1赵路军,高黎,徐国镇,李素艳,肖光莉.嗅神经母细胞瘤的预后因素和治疗结果分析[J].中华肿瘤杂志,2005,27(9):561-564. 被引量:11
  • 2Kadish S, Goodlnan M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases [J]. Cancer, 1976,37(3):1571- 1576.
  • 3Diaz EM Jr, Johnigan RH 3rd, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center [J]. Head Neck, 2005,27(2) : 138-149.
  • 4McLean JN, Nunley SR, Klass C, et al. Combined modality therapy of esthesioneuroblastoma [J]. Otolaryngology-Head and Neck Surgery, 2007,136(6) :998-1002.
  • 5Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review [J]. Lancet Oncol, 2001, 2( 11 ) :683-690.
  • 6Zafereo ME, Fakhri S, Prayson R, et al. Esthesioneuroblastoma: 25-year experience at a single institution [J]. Otolaryngol Head Neck Surg, 2008,138(4) :452-458.
  • 7Ferlito A, Rinaldo A, Rhys-Evans PH. Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck [J]. Laryngoscope, 2003,113( 11 ) : 1935-1938.
  • 8Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience [J]. Arch Otolaryngol Head Neck Surg, 2006,132(2) : 134-138.
  • 9Kiyota N, Tahara M, Fujii S, et al. Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases [J]. Cancer, 2008, 112(4):885-891.
  • 10Kim HJ, Cho HJ, Kim KS, et al. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma [ J ]. J Craniomaxillofac Surg, 2008,36 ( 1 ) :47- 52.

共引文献8

同被引文献28

  • 1张秋航.鼻内镜颅底外科的适应证[J].中国医学文摘(耳鼻咽喉科学),2006,21(2):76-78. 被引量:7
  • 2王进,柯振武,杨伟炎,王荣光.嗅神经母细胞瘤组织病理学分级与颈部淋巴结转移的关系[J].西南军医,2006,8(3):24-25. 被引量:1
  • 3NICOLAI P, BATTAGI.IA P, BIGNAMI M, et al. Endoscopic surgery for malignant tumors of the si- nonasal tract and adjacent skull base: a 10-year expe- rience[J]. Am J Rhinol,2008,22:308-316.
  • 4HANNA E, DEMONTE F, IBRAHIM S, et al. En- doscopic resection of sinonasal cancers with and with- out craniotomy: oncologic results[J]. Arch Otolaryn- gol Head Neck Surg,2009,135:1219-1224.
  • 5KOMOTAR R J, STARKER M, RAPER D M, et al. Endoscopic endonasal compared with anterior cranio- facial and combined cranionasaI resection of esthesio- neuroblastomas[J]. World Neurosurgery, 2013,80: 148-159.
  • 6VILLARET A B ,YAKIREVITCH A, BIZZONI A, et al. Endoscopic transnasal craniectomy in the man- agement of selected sinonasal malignancies[J]. Am J Rhinol Allergy, 2010,24 : 60- 65.
  • 7LUONG A, CITARDI M J , BATRA P S. Manage- ment of sinonasal malignant neoplasms: defining the role of endoscopy[J]. Am J Rhinol Allergy, 2010,24 : 50-155.
  • 8Duxbury MS, Ito H, Benoit E, et al. RNA interference demon- strates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance [J]. Clin Cancer Res, 2005, 11:3433-3438.
  • 9Takanami I. Increased expression of intelvin-linked kinase is as- sociated with shorter survival in non-small cell lung cancer[ J ]. BMC Cancer, 2005, 5:1-1.
  • 10Ito R, Oue N,Zhu X, et al. Expression of integrin linked kinase is closely correlated with invasion and metastasis gastric carcino- ma[ J]. Virchows Arch, 2003, 442:118-123.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部